Recombinant Human DLL4, N-His

Introduction

Recombinant Human DLL4, also known as Delta-like 4, is a protein that plays a crucial role in the Notch signaling pathway. This pathway is involved in various cellular processes such as cell differentiation, proliferation, and apoptosis. Recombinant Human DLL4 is produced through genetic engineering techniques and has been extensively studied for its structure, activity, and potential applications in various fields.

Structure of Recombinant Human DLL4

Recombinant Human DLL4 is a 66-kDa transmembrane protein that is composed of 685 amino acids. It belongs to the Delta/Serrate/Lag-2 (DSL) family of Notch ligands and contains a conserved Delta/Serrate/Lag-2 (DSL) domain at its N-terminus. This domain is responsible for binding to the Notch receptor and initiating the signaling cascade. The extracellular region of Recombinant Human DLL4 also contains multiple epidermal growth factor (EGF)-like repeats, which are involved in protein-protein interactions. The intracellular region of DLL4 contains a proline-rich domain that is important for its signaling activity.

Activity of Recombinant Human DLL4

Recombinant Human DLL4 is a potent activator of the Notch signaling pathway. It binds to the Notch receptor, which is present on the surface of various cells, and induces a conformational change that leads to the cleavage and release of the Notch intracellular domain (NICD). The NICD then translocates to the nucleus and regulates the expression of target genes, which are involved in various cellular processes. Recombinant Human DLL4 has been shown to play a critical role in regulating cell fate decisions, particularly in the development of blood vessels, nervous system, and immune system.

Application of Recombinant Human DLL4

Recombinant Human DLL4 has been extensively studied for its potential applications in various fields, including medicine, biotechnology, and agriculture.

1. Medicine: Recombinant Human DLL4 has shown promising results in the treatment of cancer. It has been found to inhibit tumor growth and angiogenesis, which is the process of forming new blood vessels to supply nutrients to the tumor. By blocking the Notch signaling pathway, Recombinant Human DLL4 can prevent the growth and spread of cancer cells. It has also been studied as a potential therapy for autoimmune diseases and inflammatory disorders.

2. Biotechnology: Recombinant Human DLL4 has been used in various biotechnological applications, such as protein-protein interaction studies and drug discovery. Its ability to bind to the Notch receptor and initiate the signaling cascade makes it a valuable tool for understanding the role of Notch signaling in different cellular processes. It has also been used to develop novel therapeutics that target the Notch signaling pathway.

3. Agriculture: Recombinant Human DLL4 has been studied for its potential role in improving crop yield. By regulating the Notch signaling pathway, it can enhance plant growth and development. It has also been investigated for its potential use in genetically modified crops to improve resistance against pests and diseases.

Conclusion

Recombinant Human DLL4 is a key protein in the Notch signaling pathway and has been extensively studied for its structure, activity, and potential applications. Its ability to regulate cell fate decisions makes it a promising target for various diseases, and its use in biotechnology and agriculture has shown promising results. Further research on Recombinant Human DLL4 is needed to fully understand its role in different biological processes and to develop new therapies and applications.